Overview
Buckwheat allergenic extract is used in allergenic testing.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2005/08/08 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Nelco Laboratories, Inc. | 36987-1566 | INTRADERMAL, SUBCUTANEOUS | 0.05 g in 1 mL | 12/9/2009 | |
| Nelco Laboratories, Inc. | 36987-1568 | INTRADERMAL, SUBCUTANEOUS | 0.1 g in 1 mL | 12/9/2009 | |
| Antigen Laboratories, Inc. | 49288-0051 | SUBCUTANEOUS, INTRADERMAL | 0.05 g in 1 mL | 11/17/2009 | |
| Allergy Laboratories, Inc. | 54575-358 | PERCUTANEOUS, SUBCUTANEOUS | 1 g in 20 mL | 3/15/2011 | |
| Bispit Canada Ltd. | 85631-003 | ORAL | 91 mg in 1.3 g | 8/2/2025 | |
| Nelco Laboratories, Inc. | 36987-1567 | INTRADERMAL, SUBCUTANEOUS | 0.05 g in 1 mL | 12/9/2009 | |
| Nelco Laboratories, Inc. | 36987-1569 | INTRADERMAL, SUBCUTANEOUS | 0.1 g in 1 mL | 12/9/2009 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| FAGOPYRUM ESCULENTUM | dolisos canada inc. | 02234480 | Globules
,
Liquid
,
Granules - Oral | 1 X | 1/5/1998 |
| BOROPLEX | bio active canada ltd. | 02233591 | Liquid - Oral | 1 X | 5/26/1998 |
| FAGOPYRUM-INJEEL LIQ (12D,30D,200D/1.1ML) | 02062992 | Liquid - Oral | 12 D / 1.1 ML | 12/31/1994 | |
| FAGOPYRUM-INJEEL FORTE LIQ (4D,12D,30D,200D/1.1ML) | 02063018 | Liquid - Oral | 4 D / 1.1 ML | 12/31/1994 | |
| HOMEOPATHIC MEDICINE (S#740) DPS 30C | total health centre | 02082969 | Drops - Oral | 30 C / ML | 12/31/1994 |
| UNDA 245 | seroyal international inc. | 02233243 | Liquid
,
Pellet
,
Tablet
,
Granules
,
Drops - Oral | 4 X | 4/6/1998 |
| VERMEX | bio active canada ltd. | 02233697 | Liquid - Oral | 3 X | 5/26/1998 |
| EQUISTAPLEX | bio active canada ltd. | 02233610 | Liquid - Oral | 1 X | 5/26/1998 |
| FAGOPYRUM ESCULANTUM GRANULES 1DH-30CH | dolisos laboratoires s.a. | 00768545 | Tablet - Oral | 1 DH / DH | 12/31/1988 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.